Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols

Journal article

Open access

Peer reviewed

Govindarajan Narayanan, Malcolm M Bilimoria, Peter J Hosein, Zhaohui Su, Kathleen M Mortimer and Robert C. G Martin

BMC cancer, Vol.21(1), pp.1-785

2021-12-01

PMID: 34233640

Abstract

Ablation

Irreversible electroporation

Locally advanced pancreatic cancer

Modified FOLFIRINOX

NanoKnife system

Pancreatic ductal adenocarcinoma

Study Protocol

url

https://doi.org/10.1186/s12885-021-08474-4View

Published (Version of record) Open

2 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.151 Pancreas & Gall Bladder Disorders; 1.151.395 Pancreatic Cancer
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols
Creators: Govindarajan Narayanan - Miami, FL USA
Malcolm M Bilimoria - Northwest Community Health, Arlington Heights, IL USA
Peter J Hosein - Miami, FL USA
Zhaohui Su - OM1, Inc., Boston, MA USA
Kathleen M Mortimer - OM1, Inc., Boston, MA USA
Robert C. G Martin - Louisville, KY USA
Publication Details: BMC cancer, Vol.21(1), pp.1-785
Publisher: BioMed Central
Grant note: ;
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 34233640
Record Identifier: 991031660130802976